Unlock instant, AI-driven research and patent intelligence for your innovation.

3-methyluridine and 4-methylcytidine nucleoside compounds, synthesis method and pharmaceutical use thereof

A technology of methyluridines and compounds, applied in chemical instruments and methods, medical preparations containing active ingredients, sugar derivatives, etc. Solve problems such as the synthesis of glycoside nucleoside analogues, achieve the effect of simple synthesis method and good application prospect

Inactive Publication Date: 2016-02-17
余姚市上森化学贸易有限公司
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the existing literature, the synthesis of 3-methyluridine and 4-methylcytidine nucleoside analogues of the present invention has not been seen so far, and its use in anti-HBV and anti-HIV and anti-HCV virus drugs. to report

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 3-methyluridine and 4-methylcytidine nucleoside compounds, synthesis method and pharmaceutical use thereof
  • 3-methyluridine and 4-methylcytidine nucleoside compounds, synthesis method and pharmaceutical use thereof
  • 3-methyluridine and 4-methylcytidine nucleoside compounds, synthesis method and pharmaceutical use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Synthesis of Compound 2: Compound 1 (40.0g, 79.4mmol) was dissolved in dichloromethane (400mL), hydrobromic acetic acid (45%v / v, 80mL, 433.6mmol) was added dropwise at 0°C, and it was raised to room temperature Stir overnight, after the reaction is complete, wash with saturated sodium bicarbonate solution (3×200 mL), dry over anhydrous sodium sulfate, and concentrate to dryness under reduced pressure to obtain 2 as a yellow syrup, which can be directly used in the next reaction. 525(M+H) + ,547(M+Na) + .

[0032] Synthesis of compound 3: uracil (25.3g, 226.0mmol) and ammonium sulfate (3.1g, 237.8mmol) were dissolved in hexamethyldisilazane (200mL) and stirred under reflux until the reaction was clear. After cooling to room temperature, the above Step syrup 2 was dissolved in anhydrous chloroform (400mL) and added to the above reaction solution, heated to reflux, continued to stir and react overnight, and after cooling to room temperature, the reaction solution was direc...

Embodiment 2

[0049] Synthesis of Compound 23: Compound 21 (30.0g, 64.7mmol) was dissolved in dichloromethane (300mL), and HBr / AcOH (45%v / v, 60mL, 325.2mmol) was added dropwise at 0°C, stirred at room temperature overnight , after the reaction was complete, it was washed with saturated sodium bicarbonate solution (3×200 mL), dried over anhydrous sodium sulfate, and concentrated to dryness under reduced pressure to obtain 22 as a yellow syrup, which was directly used in the next reaction. MS:423(M+H) + ,445(M+Na) + .

[0050] Uracil (19.0g, 169.5mmol) and ammonium sulfate (2.4g, 178.4mmol) were dissolved in hexamethyldisilazane (150mL) and stirred under reflux to react until clarified. After cooling to room temperature, dissolve the previous step syrup 22 Add it to the above reaction solution in anhydrous chloroform (300 mL), raise the temperature to reflux, continue to stir the reaction overnight, cool to room temperature, and directly introduce the reaction solution into the ice-water mi...

Embodiment 3

[0062] Synthesis of compound 18: weigh triazole (0.33g, 4.8mmol), dissolve in dichloromethane (10ml), add phosphorus oxychloride (0.13mL, 1.44mmol) dropwise under nitrogen protection, gradually Triethylamine (0.84ml, 4.8mmol) was added dropwise, compound 16 (0.2g, 0.48mmol) was added to the above reaction solution, and after stirring at room temperature for 2 hours, triethylamine (1.0mL) and water (0.25mL) were added Stir for a while to terminate the reaction, add dichloromethane (100mL) and saturated sodium bicarbonate solution (100mL), separate the organic phase, dry over anhydrous sodium sulfate, concentrate to dryness under reduced pressure, add 1,4-dioxane ( 10mL) and concentrated ammonia water (2mL), stirred and reacted at room temperature for 8 hours, the above reaction solution was evaporated to dryness under reduced pressure to obtain compound 18 in the form of yellow syrup, which can be directly carried out to the next step without further treatment. MS:414(M+H) + ,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a 3-methyluridine and 4-methylcytidine nucleosides compound and a synthesis method and pharmaceutical application thereof, belonging to the field of medicinal chemistry. The compound has a structural formula as shown in the specification. The compound has the effects of simultaneously modifying sugar rings and basic groups, increasing the activity of the compound and reducing the toxicity, provides a good application prospect for development of like medicines and can be applied to preparation of anti-HBV (Hepatitis B virus) medicines. The synthesis method is simple and feasible and provides conditions for mass synthesis of the compound.

Description

technical field [0001] The invention relates to nucleoside compounds, a preparation method and application thereof, in particular to 3-methyluridine and 4-methylcytidine nucleoside compounds, a synthesis method and their medicinal use, belonging to the field of medicinal chemistry. Background technique [0002] The World Health Organization estimates that there are about 2 billion hepatitis B virus (hepatitis B virus, HBV) infected people in the world, of which 350 to 400 million are chronically infected with HBV, and the number of deaths due to acute and chronic HBV infection reaches 1 million every year, and it is on the rise trend. my country is a big country with hepatitis B, accounting for 1 / 3 of it, with 120 million HBV carriers. It can be seen from the data that hepatitis B virus infection has become an important disease that endangers human health. Therefore, effective anti-HBV treatment for HBV infected patients is particularly urgent in the world, especially in my...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07H19/073C07H1/00A61K31/7072A61K31/7068A61P31/20
CPCY02P20/55
Inventor 陶乐郭晓河李玉江王强常俊标董黎红
Owner 余姚市上森化学贸易有限公司